Back to search
FDAFDA · Food and drugs·Recall number D-1062-2013

Pyridostigmine Bromide Tablets 60 mg, USP Rx Only 100 Tablets, Manufactured and Distributed by: CorePharma, LLC Middlesex, NJ 08846 NDC 64720-128-10 NDC 64720-128-10

Published October 2, 2013 · Recall initiated: July 2, 2013

Summary

FDA records drug Class II recall D-1062-2013, published October 2, 2013 and initiated July 2, 2013. Recalling firm: Core Pharma Llc; Status: Terminated; Reported quantity: 960 bottles; Lot: 109497; Exp. 12/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: Pyridostigmine Bromide tablets, is being recalled due to an out of specification test result during stablity testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Core Pharma Llc
Distributor
Nationwide
Lot
109497; Exp. 12/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pyridostigmine Bromide Tablets 60 mg, USP Rx Only 100 Tablets, Manufactured and Distributed by: CorePharma, LLC Middlesex, NJ 08846 NDC 64720-128-10 NDC 64720-128-10 recalled?

Yes. FDA published recall D-1062-2013 on October 2, 2013. Reported hazard: Failed Stability Specifications: Pyridostigmine Bromide tablets, is being recalled due to an out of specification test result during stablity testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter